Left ventricular global function index predicts incident heart failure and cardiovascular disease in young adults: the coronary artery risk development in young adults (CARDIA) study.


Journal

European heart journal. Cardiovascular Imaging
ISSN: 2047-2412
Titre abrégé: Eur Heart J Cardiovasc Imaging
Pays: England
ID NLM: 101573788

Informations de publication

Date de publication:
01 May 2019
Historique:
received: 02 07 2018
accepted: 14 09 2018
pubmed: 25 9 2018
medline: 11 8 2020
entrez: 25 9 2018
Statut: ppublish

Résumé

Left ventricular (LV) ejection fraction (LVEF) is an extensively utilized marker of LV function that is often interpreted without recourse to alterations in LV geometry and hypertrophy. LV global function index (LVGFI) is a novel marker that incorporates LV structure in the assessment of LV cardiac performance. We evaluated the prognostic utility of LVGFI from young adulthood into middle age for incident heart failure (HF) and cardiovascular disease (CVD) in comparison to LVEF. Included were 4107 CARDIA participants with echocardiograms in Year-5 (1990-1991). LVGFI was defined as LV stroke volume/LV global volume*100, where LV global volume was the sum of the LV mean cavity volume ((LV end-diastolic volume + LV end-systolic volume)/2) and myocardial volume (LV mass/density). Adjusted Cox proportional hazard models were utilized to predict incident HF and CVD outcomes. Mean age of participants was 29.8 ± 3.7 years, 55% female, and 48.7% black. Higher body mass index [beta coefficient (B) = -0.11 standard error (SE) = 0.02, P < 0.001], higher blood pressure (B = -0.04, SE = 0.01, P < 0.01), smoking (B = -0.82, SE = 0.22, P < 0.001), male sex (P < 0.001), and black race (P < 0.001) were associated with worse LVGFI. A total of 207 incident CVD events were observed over the course of 98 035 person-years at risk. Higher LVGFI was associated with HF, hazard ratio (HR) = 0.70, 95% confidence interval (CI) (0.54-0.91), hard CVD HR = 0.83, 95% CI (0.71-0.96), and all CVD HR = 0.83, 95% CI (0.72-0.96). For HF outcomes, Harrell's C-statistic for LVGFI (0.80) was greater than LVEF (0.66). LVGFI is a strong, independent predictor of incident HF and CVD that provides incremental prognostic value compared with LVEF. Male sex, black race, obesity, hypertension, and smoking are associated with worse LVGFI in the early adult lifespan.

Identifiants

pubmed: 30247530
pii: 5104438
doi: 10.1093/ehjci/jey123
pmc: PMC6477648
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

533-540

Informations de copyright

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2018. For permissions, please email: journals.permissions@oup.com.

Références

BMJ Open. 2014 Jan 02;4(1):e004001
pubmed: 24384901
J Am Soc Echocardiogr. 2017 Dec;30(12):1172-1179
pubmed: 28927559
N Engl J Med. 1990 May 31;322(22):1561-6
pubmed: 2139921
Circ Cardiovasc Imaging. 2014 May;7(3):422-9
pubmed: 24723582
Int J Cardiol. 2014 Mar 15;172(2):350-5
pubmed: 24507735
Echocardiography. 2015 Aug;32(8):1233-40
pubmed: 25382818
Nat Rev Cardiol. 2011 Oct 25;8(12):673-85
pubmed: 22027657
Heart. 2017 Apr;103(7):499-507
pubmed: 27694110
Circulation. 2018 Mar 20;137(12):e67-e492
pubmed: 29386200
J Am Coll Cardiol. 2008 Dec 16;52(25):2148-55
pubmed: 19095132
J Am Coll Cardiol. 2002 Aug 7;40(3):529-35
pubmed: 12142122
J Clin Epidemiol. 1988;41(11):1105-16
pubmed: 3204420
Circulation. 2011 Jul 5;124(1):24-30
pubmed: 21670229
Circulation. 2012 Dec 4;126(23):2713-9
pubmed: 23124035
J Am Soc Echocardiogr. 2015 Feb;28(2):183-93
pubmed: 25623220
Circulation. 1995 Aug 1;92(3):380-7
pubmed: 7634452
JACC Cardiovasc Imaging. 2014 Sep;7(9):870-8
pubmed: 25129518
J Am Coll Cardiol. 2010 Jul 27;56(5):392-406
pubmed: 20650361
Circ Cardiovasc Imaging. 2016 Jul;9(7):
pubmed: 27353852
Hypertension. 2013 Apr;61(4):770-8
pubmed: 23424238
J Am Coll Cardiol. 2011 Oct 18;58(17):1733-40
pubmed: 21996383
N Engl J Med. 2009 Mar 19;360(12):1179-90
pubmed: 19297571
Lancet. 2006 Jan 28;367(9507):356-67
pubmed: 16443044
J Cardiovasc Magn Reson. 2015 Jul 16;17:62
pubmed: 26174798
Circ Cardiovasc Imaging. 2013 Sep;6(5):769-75
pubmed: 23922005
J Am Soc Echocardiogr. 2017 Jul;30(7):647-658.e2
pubmed: 28511859
Diabetes Care. 2016 Mar;39(3):400-7
pubmed: 26740637
J Am Soc Echocardiogr. 2015 Jan;28(1):1-39.e14
pubmed: 25559473
JACC Cardiovasc Imaging. 2018 Jan;11(1):1-11
pubmed: 28917679
JACC Heart Fail. 2017 Nov;5(11):805-807
pubmed: 29096788

Auteurs

Chike C Nwabuo (CC)

Department of Medicine, Harvard Medical School, 330 Mount Auburn St, Cambridge, MA, USA.
Division of Cardiology, Johns Hopkins University School of Medicine, Johns Hopkins Hospital, 600 N. Wolfe Street, Blalock 524, Baltimore, MD, USA.

Henrique T Moreira (HT)

Division of Cardiology, Johns Hopkins University School of Medicine, Johns Hopkins Hospital, 600 N. Wolfe Street, Blalock 524, Baltimore, MD, USA.
Division of Cardiology, Universidade of Sao Paulo, Av. Bandeirantes, 3.900 Monte Alegre, Ribeirão Preto, SP, Brazil.

Henrique D Vasconcellos (HD)

Division of Cardiology, Johns Hopkins University School of Medicine, Johns Hopkins Hospital, 600 N. Wolfe Street, Blalock 524, Baltimore, MD, USA.

Nathan Mewton (N)

Division of Cardiology, Johns Hopkins University School of Medicine, Johns Hopkins Hospital, 600 N. Wolfe Street, Blalock 524, Baltimore, MD, USA.

Anders Opdahl (A)

Department of cardiology, Oslo University hospital, Sognsvannsveien 20, Oslo, Norway.

Kofo O Ogunyankin (KO)

Department of Preventive Medicine, Northwestern University, 675 N St Clair St STE 19-100, Chicago, IL, USA.

Bharath Ambale-Venkatesh (B)

Division of Cardiology, Johns Hopkins University School of Medicine, Johns Hopkins Hospital, 600 N. Wolfe Street, Blalock 524, Baltimore, MD, USA.

Pamela J Schreiner (PJ)

Division of Epidemiology and Community Health, University of Minnesota, 1300 S 2nd St, Minneapolis, MN, USA.

Anderson A C Armstrong (AAC)

Division of Cardiology, Johns Hopkins University School of Medicine, Johns Hopkins Hospital, 600 N. Wolfe Street, Blalock 524, Baltimore, MD, USA.

Cora E Lewis (CE)

Division of preventive medicine, University of Alabama, 619 19th St, Birmingham, AL, UK.

David R Jacobs (DR)

Division of Epidemiology and Community Health, University of Minnesota, 1300 S 2nd St, Minneapolis, MN, USA.

Donald Lloyd-Jones (D)

Department of Preventive Medicine, Northwestern University, 675 N St Clair St STE 19-100, Chicago, IL, USA.

Samuel S Gidding (SS)

Division of Pediatrics Cardiology, Nemours Cardiac Center, 1600 Rockland Road Wilmington, DE, USA.

João A C Lima (JAC)

Division of Cardiology, Johns Hopkins University School of Medicine, Johns Hopkins Hospital, 600 N. Wolfe Street, Blalock 524, Baltimore, MD, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH